Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanet W Blom

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
BMC Medicine|January 12, 2018
Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice - the ECSTATIC study: a cluster randomised non-inferiority trialClare H Luymes, Rosalinde K E Poortvliet, Nan van Geloven, et al.
BJU International|November 17, 2009
Pelvic floor dysfunction is not a risk factor for febrile urinary tract infection in adultsCees van Nieuwkoop, Petra J Voorham-van der Zalm, Anne-Marike van Laar, et al.
Journal of Clinical Medicine|January 1, 2021
End-of-Life Care Preferences of Older Patients with Multimorbidity: A Mixed Methods Systematic ReviewAna I González-González, Christine Schmucker, Julia Nothacker, et al.
BMC Medicine|December 9, 2014
The Ariadne principles: how to handle multimorbidity in primary care consultationsChristiane Muth, Marjan van den Akker, Jeanet W Blom, et al.
Journal of the American Geriatrics Society|January 23, 2014
Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at RiskYvonne M Drewes, Rosalinde K E Poortvliet, Jeanet W Blom, et al.
Journal of Hypertension|July 13, 2022
Disentangling the varying associations between systolic blood pressure and health outcomes in the very old: an individual patient data meta-analysisJonathan M K Bogaerts, Rosalinde K E Poortvliet, Veerle M G T H van der Klei, et al.
The Journal of Antimicrobial Chemotherapy|December 3, 2010
Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infectionWillize E van der Starre, Cees van Nieuwkoop, Sunita Paltansing, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 14, 2023
The Role of a Composite Fitness Score in the Association Between Low-Density Cholesterol and All-Cause Mortality in Older Adults: An Individual Patient Data Meta-AnalysisMilly A van der Ploeg, Rosalinde K E Poortvliet, Jonathan M K Bogaerts, et al.
BMC Infectious Diseases|August 21, 2009
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)Cees van Nieuwkoop, Jan W van't Wout, Willem J J Assendelft, et al.
Plos One|January 23, 2023
Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic modelTruc Sophia Dinh, Andreas D Meid, Henrik Rudolf, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
BMC Medicine|January 12, 2018
Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice - the ECSTATIC study: a cluster randomised non-inferiority trialClare H Luymes, Rosalinde K E Poortvliet, Nan van Geloven, et al.
BJU International|November 17, 2009
Pelvic floor dysfunction is not a risk factor for febrile urinary tract infection in adultsCees van Nieuwkoop, Petra J Voorham-van der Zalm, Anne-Marike van Laar, et al.
Journal of Clinical Medicine|January 1, 2021
End-of-Life Care Preferences of Older Patients with Multimorbidity: A Mixed Methods Systematic ReviewAna I González-González, Christine Schmucker, Julia Nothacker, et al.
BMC Medicine|December 9, 2014
The Ariadne principles: how to handle multimorbidity in primary care consultationsChristiane Muth, Marjan van den Akker, Jeanet W Blom, et al.
Journal of the American Geriatrics Society|January 23, 2014
Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at RiskYvonne M Drewes, Rosalinde K E Poortvliet, Jeanet W Blom, et al.
Journal of Hypertension|July 13, 2022
Disentangling the varying associations between systolic blood pressure and health outcomes in the very old: an individual patient data meta-analysisJonathan M K Bogaerts, Rosalinde K E Poortvliet, Veerle M G T H van der Klei, et al.
The Journal of Antimicrobial Chemotherapy|December 3, 2010
Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infectionWillize E van der Starre, Cees van Nieuwkoop, Sunita Paltansing, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 14, 2023
The Role of a Composite Fitness Score in the Association Between Low-Density Cholesterol and All-Cause Mortality in Older Adults: An Individual Patient Data Meta-AnalysisMilly A van der Ploeg, Rosalinde K E Poortvliet, Jonathan M K Bogaerts, et al.
BMC Infectious Diseases|August 21, 2009
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)Cees van Nieuwkoop, Jan W van't Wout, Willem J J Assendelft, et al.
Plos One|January 23, 2023
Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic modelTruc Sophia Dinh, Andreas D Meid, Henrik Rudolf, et al.
Pageof 8